Advertisement
News
Advertisement

AlloCure's kidney disease treatment advances

Thu, 01/05/2012 - 1:45pm
Mass High Tech: The Journal of New England Technology

The U.S. Food and Drug Administration has granted fast track designation to Burlington biotech startup AlloCure Inc. for AC607, its potential treatment of acute kidney injury (AKI).

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading